Skip to main content

Foghorn Therapeutics Inc.

corporate_fare Company Profile

Foghorn Therapeutics Inc.

FHTX·NASDAQ·Life Sciences·CIK 0001822462

Foghorn is a clinical stage, precision therapeutics biotechnology company focused on treating serious diseases by correcting abnormal gene expression. The company achieves this by selectively targeting the chromatin regulatory system, which is involved in approximately 50 percent of all cancers and has potential applications in immunology and inflammation. Foghorn utilizes its proprietary Gene Traffic Control® platform to understand how the chromatin regulatory system interacts, enabling the identification and validation of drug targets within this system. The company is currently working on more than seven programs, with one clinical-stage drug candidate in Phase 1 development. Foghorn has discovered selective chemical matter for oncology targets including SMARCA2 (BRM), CBP, EP300, and ARID1B, along with other undisclosed targets. The company employs a small molecule modality agnostic approach, including protein degraders, allosteric enzymatic inhibitors, and transcription factor disruptors. As part of a collaboration with Eli Lilly and Company, Lilly initiated a Phase 1 dose escalation trial for FHD-909 (LY4050784), a selective ATPase inhibitor of SMARCA2, with the first patient dosed in October 2024.

Foghorn Therapeutics Inc. (NASDAQ:FHTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for FHTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for FHTX spans 8-K, 10-Q, DEF 14A, 10-K.

Recent high-impact activity:

  • Foghorn Swings to $58.2M Q3 Profit on $74.1M Catch-Up Adjustment, Cash Runway to 2029
  • Foghorn Swings to $58.2M Q3 Net Income, Extends Cash Runway to 2H 2029
  • Foghorn Halts FHD-909 and SMARCA2 Programs, Cuts 40% of Workforce
  • Foghorn Halts FHD-909, Cuts 40% of Staff, Extends Runway to 2029
  • Foghorn Therapeutics Q1 Revenue Plunges 45% to $3.3M, Net Loss Widens

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$30.91M
Net Income
-$74.28M
Diluted EPS
-$1.18
Op. Cash Flow
-$86.1M
Free Cash Flow
-$86.15M
Operating Income
-$86.39M
Cash & Equivalents
$80.88M
Debt / Equity
0.00×
Net Margin
-240.3%
Shares Outstanding
56.66M sh
Source: 10-K · filed 2026-03-11 · accession 0001628280-26-016814

Short Interest & Short Volume

3.90 days to cover

FINRA reported short interest of 2,251,943 shares in FHTX as of the October 30, 2026 settlement, a 8.3% decrease from the prior period — about 3.9 days to cover at its recent average daily volume. On November 20, 2026, 31.0% of FHTX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,251,943 shares as of October 30, 2026
Change vs prior period▼ 8.3%
Days to cover3.90 at avg daily volume of 577,107
Daily short volume (FINRA facilities)31.0% of 362,702 shares on November 20, 2026
5-day average short volume38.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with F →
$1.66 -3.49% today
52-week range · as of 2026-11-09 $1.66 – $7.61
Market cap
$103.14M
Volume
919.9K (1.3× avg)
3-mo avg 725.6K
Live data · 2026-11-21 23:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed FHTX - Latest Insights

FHTX
Nov 09, 2026, 7:31 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.87
Real-time Price: $1.66 info
Change: -$0.210 (-11%) info
Market Cap: $103.136M info
FHTX
Nov 09, 2026, 7:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.87
Real-time Price: $1.66 info
Change: -$0.210 (-11%) info
Market Cap: $103.136M info
FHTX
Oct 01, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
9
Updated Oct 1, 1:19 PM ET — Foghorn shares fell 27.17% to $2.60, a new 52-week low, on volume of 9.158 million.
Price at Filing: $3.57
Real-time Price: $1.66 info
Change: -$1.91 (-54%) info
Market Cap: $103.136M info
FHTX
Oct 01, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.57
Real-time Price: $1.66 info
Change: -$1.91 (-54%) info
Market Cap: $103.136M info
FHTX
May 07, 2026, 7:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.68
Real-time Price: $1.66 info
Change: -$3.02 (-65%) info
Market Cap: $103.136M info
FHTX
May 07, 2026, 7:02 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.68
Real-time Price: $1.66 info
Change: -$3.02 (-65%) info
Market Cap: $103.136M info
FHTX
May 07, 2026, 7:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.68
Real-time Price: $1.66 info
Change: -$3.02 (-65%) info
Market Cap: $103.136M info
FHTX
Apr 30, 2026, 7:00 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $4.61
Real-time Price: $1.66 info
Change: -$2.95 (-64%) info
Market Cap: $103.136M info
FHTX
Apr 21, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $1.66 info
Change: -$3.61 (-69%) info
Market Cap: $103.136M info
FHTX
Apr 21, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $1.66 info
Change: -$3.61 (-69%) info
Market Cap: $103.136M info
FHTX
Mar 11, 2026, 4:11 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $5.65
Real-time Price: $1.66 info
Change: -$3.99 (-71%) info
Market Cap: $103.136M info
FHTX
Feb 23, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.73
Real-time Price: $1.66 info
Change: -$4.07 (-71%) info
Market Cap: $103.136M info
FHTX
Jan 13, 2026, 5:09 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $6.79
Real-time Price: $1.66 info
Change: -$5.13 (-76%) info
Market Cap: $103.136M info
FHTX
Jan 12, 2026, 4:48 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $6.27
Real-time Price: $1.66 info
Change: -$4.61 (-74%) info
Market Cap: $103.136M info
FHTX
Jan 12, 2026, 8:50 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.35
Real-time Price: $1.66 info
Change: -$3.69 (-69%) info
Market Cap: $103.136M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets